SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Microcap & Penny StocksMicrocap Kitchen Canadian Stocks


Previous 10 Next 10 
To: 31Floors who wrote (49044)8/6/2019 8:37:33 PM
From: 31Floors
   of 49216
 
..two gong shows and then you add in GRB's track record to that mix? And that's why I sold.

Share RecommendKeepReplyMark as Last Read


From: kidl8/7/2019 9:44:19 AM
1 Recommendation   of 49216
 
ENW ... This bodes well for future royalty revenue.

New Outdoor Cultivation Site in Portugal

Additional 20 hectares of outdoor growing space increases company’s capacity to supply medical cannabis across Europe and to other international markets

businesswire.com

Share RecommendKeepReplyMark as Last Read


From: 31Floors8/9/2019 12:42:29 AM
   of 49216
 
IPA is hosting a tour of its world class therapeutic antibodies lab in Victoria on Wed August 14 for shareholders. The event will be hosted by CEO Dr Jennifer Bath. It starts at 2:00 pm followed by a social event at 4:00. More information and RSVP details here:

immunoprecise.com

A six minute YouTube interview:

m.youtube.com

IPA is in the doghouse, I get it. I was pissed off at it too after buying into the $1 pp. I sold it all but I've re-entered because operationally good things ARE happening.

immunoprecise.com

New IPA sub Talem is cool because IPA isn't going to be just a fee for services contractor (CRO). Talem's role as I understand it will be to collaborate with pharmaceutical and biotechs, and take some form of ownership interest (royalties?) in discovery projects. I'm hearing there is a lot of interest flowing into the co. It makes sense. A lousy analogy is like IPA providing the shovels to miners; except they are the ones that know how to use the shovels and it ain't anything like shovels.

immunoprecise.com

There's been a lot of news recently on artificial intelligence. I know that IPA has been working on AI for some time. I don't know much more than that. They won't be expecting this, they may not want to say much; but It'll be an opportunity to see sneak in some questions on AI, anyway.

bloomberg.com

31

Share RecommendKeepReplyMark as Last Read


From: 31Floors8/9/2019 5:39:38 PM
   of 49216
 
IPA wants to emulate Invitrogen .

biotech-capital.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: 31Floors who wrote (49048)8/9/2019 5:57:51 PM
From: 31Floors
   of 49216
 
I should have credited Hotspurs on SH for the link I just posted. Ball's in IPA's court to execute.

Share RecommendKeepReplyMark as Last Read


From: kidl8/14/2019 11:37:11 AM
   of 49216
 
ENW ...EnWave Corporation Added to the NYSE Listed “The Cannabis ETF”

VANCOUVER, British Columbia, Aug. 14, 2019 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) reports today that it has been added to The Cannabis ETF (NYSE:THCX) (“THCX”) which trades on the New York Stock Exchange. THCX follows the Innovation Labs Cannabis Index, which is a portfolio of 35 holdings expected to benefit from growth of the legal marijuana, CBD and hemp industries.

Mr. Brent Charleton, President and CEO of EnWave Corporation, remarks. “We’re excited about the access this fund provides for U.S. based investors. We’re proud of the progress we’ve made with our proprietary REV™ technology in the legal cannabis sector and we will continue to work towards securing partners in this rapidly growing sector.”

EnWave currently has three royalty-bearing commercial license agreements with Canadian cannabis companies and one royalty-bearing commercial license agreement with a hemp producer in the United States.

On June 3, 2019, EnWave was added to the Horizon Marijuana Life Sciences Index ETF (TSX:HMMJ) (“HMMJ”). HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that are involved with marijuana bioengineering and production. HMMJ has added additional companies to its portfolio as more firms have become eligible for inclusion in its underlying index – the North American Marijuana Index.

For more information on The Cannabis ETF (NYSE:THCX), please visit: thcxetf.com and thcxetf.com.

For more information on Horizon Marijuana Life Sciences Index ETF (TSX:HMMJ), please visit: horizonsetfs.com.

Share RecommendKeepReplyMark as Last Read


From: kidl8/14/2019 3:59:56 PM
   of 49216
 
ENW ... Tilray Q Results ... TLRY shareholders are clearly not very happy but from ENW’s point of view these results and Kennedy’s approach are beneficial as ENW’s royalty is based on sales and not on TLRY’s bottom line.



FP/wire say Tilray mum on interest in Canntrust assets

The Financial Post reports in its Wednesday, Aug. 14, edition that Tilray posted a wider-than-expected second quarter loss on Tuesday. A Bloomberg dispatch to the Post reports that although revenue of $45.9-million was ahead of the consensus estimate of $40.3-million, investors appeared to focus on the $17.9-million loss before interest, taxes, depreciation and amortization (all figures U.S.). That was wider than the $14.4-million expected by analysts and comes as pot investors are increasingly focused on profitability. Tilray said the higher loss was due to rising operating costs related to growth initiatives, interest expense from its convertible notes, recent acquisitions and the expansion of its international operations. Chief executive officer Brendan Kennedy said he is sanguine about the company's ongoing losses. He said if you want to "dominate" the "global industry, you'd be constraining yourself if you were focused on profitability at this point." He said, "Globally, now's the time to invest." The Canntrust Holdings regulatory breach is "an infuriating situation," Mr. Kennedy said. He would not comment on whether Tilray is interested in acquiring any of Canntrust's assets.

© 2019 Canjex Publishing Ltd.

Share RecommendKeepReplyMark as Last Read


To: JohnnyMoney who wrote (49036)8/20/2019 4:41:53 PM
From: WorthaDeeperLook
   of 49216
 
AKR.v - I am still following and still our largest position in the Rivemont Microcap Fund.

News out recently.

Best quarter in their young history: ACKROO ANNOUNCES Q2 2019 FINANCIAL RESULTS

Significant organic growth opportunity: ACKROO LAUNCHES ACKROOPAY

Not much for sale until 20+ cents.

Share RecommendKeepReplyMark as Last Read


To: WorthaDeeperLook who wrote (49035)8/20/2019 4:44:23 PM
From: WorthaDeeperLook
   of 49216
 
BTV.v - Bluerush receives $810,000 (U.S.) contract

IndiVideo's growth is accelerating. High growth potentiel stock imo.

Share RecommendKeepReplyMark as Last Read


From: WorthaDeeperLook8/20/2019 4:46:47 PM
   of 49216
 
UI.v - Blowout quarter!

URBANIMMERSIVE ANNOUNCES A RECORD THIRD QUARTER 2019

I expect them to do at least 1M in EBITDA in the next 12 months, which should be enough to service their debt, without factoring any growth.

Stock price action before Q3 was suggesting a refinancing was going to happen but the market was wrong. Price target 10+ cents.

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10